Morgan Stanley’s NextCure NXTC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1
| Closed | -$1 | – | 8182 |
|
|
2024
Q4 | $1 | Hold |
1
| – | – | ﹤0.01% | 7960 |
|
|
2024
Q3 | $1 | Hold |
1
| – | – | ﹤0.01% | 7920 |
|
|
2024
Q2 | $2 | Sell |
1
-402,257
| -100% | -$805K | ﹤0.01% | 7832 |
|
|
2024
Q1 | $897K | Buy |
402,258
+240,602
| +149% | +$537K | ﹤0.01% | 5019 |
|
|
2023
Q4 | $184K | Buy |
161,656
+161,655
| +16,165,500% | +$184K | ﹤0.01% | 5974 |
|
|
2023
Q3 | $1 | Sell |
1
-300
| -100% | -$300 | ﹤0.01% | 7603 |
|
|
2023
Q2 | $542 | Sell |
301
-118,039
| -100% | -$213K | ﹤0.01% | 7372 |
|
|
2023
Q1 | $175K | Buy |
118,340
+87,981
| +290% | +$130K | ﹤0.01% | 5763 |
|
|
2022
Q4 | $42.8K | Sell |
30,359
-12,052
| -28% | -$17K | ﹤0.01% | 6359 |
|
|
2022
Q3 | $117K | Sell |
42,411
-2,946
| -6% | -$8.13K | ﹤0.01% | 6000 |
|
|
2022
Q2 | $213K | Sell |
45,357
-25,083
| -36% | -$118K | ﹤0.01% | 5865 |
|
|
2022
Q1 | $342K | Sell |
70,440
-2,460
| -3% | -$11.9K | ﹤0.01% | 5607 |
|
|
2021
Q4 | $438K | Sell |
72,900
-82,592
| -53% | -$496K | ﹤0.01% | 5621 |
|
|
2021
Q3 | $1.05M | Sell |
155,492
-420,953
| -73% | -$2.84M | ﹤0.01% | 5013 |
|
|
2021
Q2 | $4.63M | Sell |
576,445
-401,795
| -41% | -$3.23M | ﹤0.01% | 3861 |
|
|
2021
Q1 | $9.79M | Sell |
978,240
-1,203,378
| -55% | -$12M | ﹤0.01% | 2680 |
|
|
2020
Q4 | $23.8M | Buy |
2,181,618
+1,113,220
| +104% | +$12.1M | ﹤0.01% | 1643 |
|
|
2020
Q3 | $9.4M | Buy |
1,068,398
+736,838
| +222% | +$6.48M | ﹤0.01% | 2084 |
|
|
2020
Q2 | $7.11M | Buy |
331,560
+324,064
| +4,323% | +$6.95M | ﹤0.01% | 2304 |
|
|
2020
Q1 | $278K | Sell |
7,496
-18,066
| -71% | -$670K | ﹤0.01% | 4721 |
|
|
2019
Q4 | $1.44M | Buy |
25,562
+14,731
| +136% | +$830K | ﹤0.01% | 4278 |
|
|
2019
Q3 | $334K | Buy |
10,831
+4,062
| +60% | +$125K | ﹤0.01% | 4875 |
|
|
2019
Q2 | $101K | Buy |
+6,769
| New | +$101K | ﹤0.01% | 5316 |
|